Shamilene Sivagnanam

13PUBLICATIONS
127CO-AUTHORS
Tumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 24, 2026
IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma.

|Sep 04, 2026
The post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

|May 21, 2026
Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

|Mar 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts Anti-PD-1 Efficacy in Transgenic Mammary Tumors.

Amanda Poissonnier, Hope S Rugo, Wesley Horton

|Feb 12, 2026
ImmunoPheno: A Computational Framework for Data-Driven Design and Analysis of Immunophenotyping Experiments.

Lincoln Wu, Minh A Nguyen, Zhangliang Yang

|Oct 23, 2025
Neoplastic Immune Mimicry Potentiates Breast Tumor Progression.

Eric B Berens, Sokchea Khou, Elaine T Huang

Pageof 3

Frequent Collaborators

13 joint publications

Lisa M Coussens

7 joint publications

Nell Kirchberger

7 joint publications

Katie E Blise

6 joint publications

Rosalie C Sears